Literature DB >> 17224124

Generation of a homology model for the human cytochrome P450, CYP24A1, and the testing of putative substrate binding residues by site-directed mutagenesis and enzyme activity studies.

Sonoko Masuda1, David E Prosser, Yu-Ding Guo, Martin Kaufmann, Glenville Jones.   

Abstract

A systematic analysis of conserved H-bonding patterns and tertiary structural motifs from 13 crystal structures was used to create a homology model for the human multicatalytic cytochrome P450, CYP24A1, involved in catabolism of 1alpha,25-dihydroxyvitamin D3. The substrate was docked in the active site and used to identify potential substrate contact residues in the B' helix, B'/C loop, F-helix and the beta-5 hairpin. Seven CYP24A1 mutants were created and studied by mammalian cell transfection and CYP24A1 activity assay. Mutants showed reduced metabolic rates and altered metabolite patterns compared to wild-type. We conclude that: Ile-131 positions substrate via A-ring and cis-triene contacts; Trp-134 and Gly-499 are determinants of substrate access; Leu-148 contacts the substrate side-chain; Met-246 is important in mediating regioselectivity. Our findings validate the new model of CYP24A1, which can now be used to predict structural modifications for rational vitamin D drug design.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17224124     DOI: 10.1016/j.abb.2006.11.030

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  10 in total

1.  Single A326G mutation converts human CYP24A1 from 25-OH-D3-24-hydroxylase into -23-hydroxylase, generating 1alpha,25-(OH)2D3-26,23-lactone.

Authors:  David E Prosser; Martin Kaufmann; Brendan O'Leary; Valarie Byford; Glenville Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-23       Impact factor: 11.205

2.  Comparative docking studies of CYP1b1 and its PCG-associated mutant forms.

Authors:  Malkaram Sridhar Achary; Hampapathalu Adimurthy Nagarajam
Journal:  J Biosci       Date:  2008-12       Impact factor: 1.826

Review 3.  Cytochrome P450-mediated metabolism of vitamin D.

Authors:  Glenville Jones; David E Prosser; Martin Kaufmann
Journal:  J Lipid Res       Date:  2013-04-06       Impact factor: 5.922

4.  1,25-(OH)2D-24 Hydroxylase (CYP24A1) Deficiency as a Cause of Nephrolithiasis.

Authors:  Galina Nesterova; May Christine Malicdan; Kaori Yasuda; Toshiyuki Sakaki; Thierry Vilboux; Carla Ciccone; Ronald Horst; Yan Huang; Gretchen Golas; Wendy Introne; Marjan Huizing; David Adams; Cornelius F Boerkoel; Michael T Collins; William A Gahl
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-04       Impact factor: 8.237

5.  Bioengineering anabolic vitamin D-25-hydroxylase activity into the human vitamin D catabolic enzyme, cytochrome P450 CYP24A1, by a V391L mutation.

Authors:  Martin Kaufmann; David E Prosser; Glenville Jones
Journal:  J Biol Chem       Date:  2011-06-22       Impact factor: 5.157

6.  A new insight into the role of rat cytochrome P450 24A1 in metabolism of selective analogs of 1α,25-dihydroxyvitamin D₃.

Authors:  Steve Y Rhieu; Andrew J Annalora; Rose M Gathungu; Paul Vouros; Milan R Uskokovic; Inge Schuster; G Tayhas R Palmore; G Satyanarayana Reddy
Journal:  Arch Biochem Biophys       Date:  2011-02-19       Impact factor: 4.013

7.  Crystal structure of CYP24A1, a mitochondrial cytochrome P450 involved in vitamin D metabolism.

Authors:  Andrew J Annalora; David B Goodin; Wen-Xu Hong; Qinghai Zhang; Eric F Johnson; C David Stout
Journal:  J Mol Biol       Date:  2009-12-01       Impact factor: 5.469

8.  Cytochrome P450 125 (CYP125) catalyses C26-hydroxylation to initiate sterol side-chain degradation in Rhodococcus jostii RHA1.

Authors:  Kamila Z Rosłoniec; Maarten H Wilbrink; Jenna K Capyk; William W Mohn; Martin Ostendorf; Robert van der Geize; Lubbert Dijkhuizen; Lindsay D Eltis
Journal:  Mol Microbiol       Date:  2009-10-15       Impact factor: 3.501

Review 9.  Association of the CYP24A1-rs2296241 polymorphism of the vitamin D catabolism enzyme with hormone-related cancer risk: a meta-analysis.

Authors:  Ping Wang; Hemei Zhang; Zengli Zhang; Liqiang Qin; Bingyan Li
Journal:  Onco Targets Ther       Date:  2015-05-22       Impact factor: 4.147

10.  A theoretical insight to understand the molecular mechanism of dual target ligand CTA-018 in the chronic kidney disease pathogenesis.

Authors:  Selvaraman Nagamani; Karthikeyan Muthusamy
Journal:  PLoS One       Date:  2018-10-04       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.